{
"NDC": {
"NDCCode": "71309-461-56",
"PackageDescription": "56 TABLET, EXTENDED RELEASE in 1 BOTTLE (71309-461-56) ",
"NDC11Code": "71309-0461-56",
"ProductNDC": "71309-461",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Guaifenesin",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Guaifenesin",
"DosageFormName": "TABLET, EXTENDED RELEASE",
"RouteName": "ORAL",
"StartMarketingDate": "20201218",
"EndMarketingDate": null,
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA213420",
"LabelerName": "Safrel Pharmaceuticals, LLC.",
"SubstanceName": "GUAIFENESIN",
"StrengthNumber": "1200",
"StrengthUnit": "mg/1",
"Pharm_Classes": "Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2023-03-29",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20261231",
"StartMarketingDatePackage": "20220629",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}